# Philips to acquire BioTelemetry for $2.8 billion

Royal Philips announced a definitive agreement to acquire BioTelemetry, Inc. for $72.00 per share, implying an enterprise value of $2.8 billion, to expand patient care management solutions.

- Type: Acquisition
- Announced: 2020-12-18
- Where: United States
- Value: $2.80B
- Status: announced
- Products: cardiac diagnostics and monitoring, wearable heart monitors, AI-based data analytics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Royal Philips](https://endata.com/companies/25215.md) (acquirer)
- [BioTelemetry, Inc.](https://endata.com/companies/52000.md) (target)
- [Capsule Technologies](https://endata.com/companies/52621.md) (target)

## Sources

- [philips.com](https://www.philips.com/a-w/about/news/archive/standard/news/press/2020/20201218-philips-to-become-a-global-leader-in-patient-care-management-solutions-for-the-hospital-and-the-home-through-the-acquisition-of-biotelemetry-inc.html), 2020-12-18: "The acquisition of BioTelemetry is a strong fit with Philips’ cardiac care portfolio, and its strategy to transform the delivery of care along the health continuum with integrated solutions."
- [philips.com](https://www.philips.com/a-w/about/news/archive/standard/news/press/2021/20210119-philips-to-expand-its-leadership-in-patient-care-management-solutions-for-the-hospital-with-the-acquisition-of-capsule-technologies-inc.html), 2021-01-19: "The acquisition of Capsule is a strong fit with Philips’ strategy to transform the delivery of care along the health continuum with integrated solutions."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.